Biden Again Tests Positive for COVID, in a ‘Rebound’ Case – CNET

For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.

The news about Biden comes amid concern about Omicron BA.5, the new, extremely contagious variant of COVID.
In a memo released Saturday, O’Connor said there’s no need for additional treatment at this time but that close observation of the president’s condition would continue.
Biden tweeted out a brief note about the new positive test on Saturday morning and later tweeted a quick update video, saying, “I’m feeling fine, everything’s good” and adding that he’d be “working from home” for the next couple of days. 
O’Connor said Biden had been testing more frequently for the coronavirus because of the possibility of a COVID recurrence following his treatment with Paxlovid, an oral medication used to prevent severe cases.
US President Joe Biden tested positive again for COVID-19 late Saturday morning after negative tests for several days, but no symptoms have reemerged and the president “continues to feel quite well,” said White House physician Kevin O’Connor.
Read more: What We Know About Omicron BA.5
Biden, who’s fully vaccinated and double boosted, started taking Paxlovid after testing positive for COVID on July 21. He experienced only mild coronavirus symptoms, including a runny nose, fatigue and an occasional cough.
On Monday, O’Connor said Biden’s symptoms had “almost completely resolved,” and on Wednesday, the physician said Biden had completed his five-day course of Paxlovid and that he’d tested negative for the first time on Tuesday evening.

O’Connor said Biden would “reinitiate strict isolation procedures” to avoid the possibility of infecting others.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives. The US Centers for Disease Control and Prevention said in an advisory earlier this year that a small number of participants in a clinical trial of Paxlovid had positive test results after testing negative. The agency said that in those cases, the recurrence of illness improved or resolved without additional treatment in an average of three days.